FRA:SAE - Deutsche Boerse Ag - NL0012044747 - Common Stock - Currency: EUR
FRA:SAE (6/12/2023, 7:00:00 PM)
88.3
-0.58 (-0.65%)
The current stock price of SAE.DE is 88.3 EUR. In the past month the price decreased by -6.24%. In the past year, price decreased by -0.27%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
W8A.DE | WALGREENS BOOTS ALLIANCE INC | 3.77 | 8.50B | ||
RDC.DE | REDCARE PHARMACY NV | N/A | 2.36B | ||
TALEA.MI | TALEA GROUP SPA | N/A | 42.00M |
Shop Apotheke Europe NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. The company is headquartered in Sevenum, Limburg and currently employs 1,847 full-time employees. The company went IPO on 2016-10-13. The firm focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The firm is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
SHOP APOTHEKE EUROPE NV
Erik de Rodeweg 11/13
Sevenum LIMBURG NL
Employees: 1847
Company Website: https://shop-apotheke-europe.com/
The current stock price of SAE.DE is 88.3 EUR. The price decreased by -0.65% in the last trading session.
The exchange symbol of SHOP APOTHEKE EUROPE NV is SAE and it is listed on the Deutsche Boerse Ag exchange.
SAE.DE stock is listed on the Deutsche Boerse Ag exchange.
18 analysts have analysed SAE.DE and the average price target is 95.37 EUR. This implies a price increase of 8.01% is expected in the next year compared to the current price of 88.3. Check the SHOP APOTHEKE EUROPE NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SHOP APOTHEKE EUROPE NV (SAE.DE) has a market capitalization of 1.63B EUR. This makes SAE.DE a Small Cap stock.
SHOP APOTHEKE EUROPE NV (SAE.DE) currently has 1847 employees.
SHOP APOTHEKE EUROPE NV (SAE.DE) has a support level at 88.29 and a resistance level at 93.99. Check the full technical report for a detailed analysis of SAE.DE support and resistance levels.
The Revenue of SHOP APOTHEKE EUROPE NV (SAE.DE) is expected to grow by 21.52% in the next year. Check the estimates tab for more information on the SAE.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SAE.DE does not pay a dividend.
SHOP APOTHEKE EUROPE NV (SAE.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.57).
ChartMill assigns a technical rating of 6 / 10 to SAE.DE. When comparing the yearly performance of all stocks, SAE.DE is one of the better performing stocks in the market, outperforming 79.17% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to SAE.DE. SAE.DE has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months SAE.DE reported a non-GAAP Earnings per Share(EPS) of -3.57. The EPS increased by 29.57% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | 0.72 |
ChartMill assigns a Buy % Consensus number of 73% to SAE.DE. The Buy consensus is the average rating of analysts ratings from 18 analysts.
For the next year, analysts expect an EPS growth of 46.26% and a revenue growth 21.52% for SAE.DE